| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |